Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine candidates, made by ...

Yes, adults can get RSV (respiratory syncytial virus). In fact, most adults have had an RSV infection at least once in their lives. This seasonal virus is so widespread that almost all of us have had ...

Data shows that ER visits and hospital admissions for RSV have been climbing in New Jersey since early October. Currently, ER ...

All older adults over the age of 80 will now be eligible for the RSV vaccine. The RSV vaccine has been routinely available to ...

Respiratory viruses are usually most active from October through March, health officials say.

The panel said seniors should use "shared clinical decision-making," which involves working with their healthcare provider to decide how much they will benefit from a shot. Outgoing CDC director ...

"Current vaccine recommendations continue to stratify by age but need to better incorporate risk from the presence of chronic medical conditions at any age." — Angela Branche, MD, Associate Professor ...

This week in JAMA Network Open, a team led by researchers from respiratory syncytial virus (RSV) vaccine-maker Pfizer ...

RSV hospitalization rates in older adults reached 58.3 per 100,000 in winter 2023-24, nearly half the rate of influenza at 114.6 per 100,000. Mortality and clinical outcomes were comparable between ...

RSV vaccination for adults aged 60+ could prevent significant LRTD cases, hospitalizations, and deaths over five years. A 5-percentage-point increase in vaccine uptake could avert over 222,000 LRTD ...